Investigating Dyadic Expectations About ARF Survivorship (IDEAS)
Johns Hopkins University
235 participants
Jul 23, 2024
OBSERVATIONAL
Conditions
Summary
The purpose of this observational study is to understand how adults who survive acute respiratory failure (ARF) and the people (usually family) who support ARF survivors after returning home think about the first 6 months of recovery. The study aims to find out if expectations about the recovery process after ARF are associated with mental health symptoms in both survivors and the survivor's care partners. Study participants will complete 3 surveys over 6 months. These surveys ask questions about participants' future expectations, feelings, and mood. Surveys can be completed online, over the phone, or on paper.
Eligibility
Inclusion Criteria12
- ≥18 years old
- Meets study definition of ARF:
- The study defines ARF as meeting 1 of the following 3:
- Mechanical ventilation via an endotracheal tube ≥24 consecutive hours OR
- Non-invasive ventilation (CPAP, BiPAP) ≥24 consecutive hours that is not for obstructive sleep apnea or other stable use OR
- High flow nasal cannula with fraction of inspired oxygen (FIO2)≥.5 and flow rate ≥ litres per minute (LPM) for ≥24 consecutive hours.
- Occasional rest periods of ≤1 hour are not deducted from the calculation of consecutive hours. Patients who are intubated for mental status or airway obstruction are not eligible unless they have simultaneous ARF.
- Survival to hospital discharge to home
- Speaks or reads English or Spanish
- Identifies an adult who is expected to act as a primary care partner for at least the next 6 months.
- ≥18 years old
- Speaks or reads English or Spanish
Exclusion Criteria5
- Pre-existing cognitive impairment (IQ-CODE \>3.6)
- Residing in a medical institution at hospital discharge
- Receiving hospice care or life expectancy \<6 months
- Homelessness or recent history of psychosis
- Pre-existing cognitive impairment (IQ-CODE \>3.6)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Dyad members' expectations will be collected at baseline and at 3- month follow-up assessments using a visual analogue scale (VAS) ranging from 0 - 100, similar to the EQ-5D-VAS.
Self-efficacy in both dyad members will be assessed at 3- and 6-month follow-up assessments using the Generalized Self-Efficacy Scale (GSE). The GSE has 10 items scored on a 4-point scale. U.S. adult population norms are available.
Dyad members' expectations will be collected at baseline and at 3- month follow-up assessments using a visual analogue scale (VAS) ranging from 0 - 100, similar to the EQ-5D-VAS.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06401239